1. Ren, Li-Kun, Lu, Ri-Shang, Fei, Xiao-Bin, Wang, Xing, Pan, Yao-Zhen. 2024. Unveiling the role of PYGB in pancreatic cancer: a novel diagnostic biomarker and gene therapy target. In Journal of cancer research and clinical oncology, 150, 127. doi:10.1007/s00432-024-05644-2. https://pubmed.ncbi.nlm.nih.gov/38483604/
2. Zhang, Shuwei, Zhou, Yichi, Zha, Yuanyu, Li, Jingfeng, Jin, Wei. 2018. PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines. In Molecular medicine reports, 18, 715-722. doi:10.3892/mmr.2018.9022. https://pubmed.ncbi.nlm.nih.gov/29845265/
3. Huang, Yatao, Li, Shuai, Wang, Youde, Guo, Yachun, Zhang, Liying. 2023. A Novel 5-Chloro-N-phenyl-1H-indole-2-carboxamide Derivative as Brain-Type Glycogen Phosphorylase Inhibitor: Validation of Target PYGB. In Molecules (Basel, Switzerland), 28, . doi:10.3390/molecules28041697. https://pubmed.ncbi.nlm.nih.gov/36838691/
4. Wang, Guoying, Ni, Xin, Wang, Jintian, Dai, Ming. 2023. METTL3-mediated m6A methylation of PYGB facilitates pancreatic ductal adenocarcinoma progression through the activation of NF-κB signaling. In Pathology, research and practice, 248, 154645. doi:10.1016/j.prp.2023.154645. https://pubmed.ncbi.nlm.nih.gov/37422970/
5. Chong, Andrew, Joshua, Jessica, Raheb, Shari, Caswell, Jeff L, Fonfara, Sonja. 2024. Evaluation of potential novel biomarkers for feline hypertrophic cardiomyopathy. In Research in veterinary science, 180, 105430. doi:10.1016/j.rvsc.2024.105430. https://pubmed.ncbi.nlm.nih.gov/39395261/
6. Li, Xiaofeng, Yu, Ranran, Shi, Baochang, Zhang, Kai, Liang, Li. 2024. Liquid-liquid phase separation-related features of PYGB/ACTR3/CCNA2/ITGB1/ATP8A1/RAP1GAP2 predict the prognosis of pancreatic cancer. In Journal of gastrointestinal oncology, 15, 1723-1745. doi:10.21037/jgo-24-426. https://pubmed.ncbi.nlm.nih.gov/39279964/
智鼠故事 
